Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Robert

Showing results (31-40 of 512) with videos related to

Pageof 52
Sort By:
JAMA Oncology|August 12, 2021
Association of Adjuvant Immunotherapy Duration With Chronic Immune-Related Adverse EventsElie Rassy, Barbara Pistilli, Caroline Robert
European Journal of Cancer (Oxford, England : 1990)|August 2, 2011
New drugs in melanoma: it's a whole new worldAlexander M M Eggermont, Caroline Robert
Nature Medicine|December 16, 2022
Using genetics to predict toxicity of cancer immunotherapyCaroline Robert, Stéphan Vagner, Xavier Mariette
Annales De Pathologie|January 24, 2017
[Tissue biomarkers of response to anti-PD-1 immunotherapies in melanoma]Julien Adam, Gorana Tomasic, Caroline Robert
Nature Reviews. Clinical Oncology|March 5, 2014
Melanoma: smart therapeutic strategies in immuno-oncologyAlexander M M Eggermont, Caroline Robert
Bulletin Du Cancer|March 18, 2015
[Immunotherapies and melanoma]Émilie Routier, Caroline Robert, Christina Mateus
Hematology/Oncology Clinics of North America|July 24, 2024
Progress in Immune Checkpoint Inhibitor for Melanoma TherapyCeline Boutros, Hugo Herrscher, Caroline Robert
La Revue Du Praticien|October 15, 2020
[Immune checkpoint inhibitors for treatment of advanced stage melanoma]Jeremy Lupu, Hugo Herrscher, Caroline Robert
Melanoma Research|September 5, 2014
MAP-kinase pathway up or down? Just look at the skin of your patients!Caroline Robert, Marina Thomas, Christina Mateus
Progress in Tumor Research|September 19, 2015
Immune Checkpoint InhibitorsJohn B A G Haanen, Caroline Robert
Pageof 52

Showing results (31-40 of 512) with videos related to

Sort By:
Pageof 52
JAMA Oncology|August 12, 2021
Association of Adjuvant Immunotherapy Duration With Chronic Immune-Related Adverse EventsElie Rassy, Barbara Pistilli, Caroline Robert
European Journal of Cancer (Oxford, England : 1990)|August 2, 2011
New drugs in melanoma: it's a whole new worldAlexander M M Eggermont, Caroline Robert
Nature Medicine|December 16, 2022
Using genetics to predict toxicity of cancer immunotherapyCaroline Robert, Stéphan Vagner, Xavier Mariette
Annales De Pathologie|January 24, 2017
[Tissue biomarkers of response to anti-PD-1 immunotherapies in melanoma]Julien Adam, Gorana Tomasic, Caroline Robert
Nature Reviews. Clinical Oncology|March 5, 2014
Melanoma: smart therapeutic strategies in immuno-oncologyAlexander M M Eggermont, Caroline Robert
Bulletin Du Cancer|March 18, 2015
[Immunotherapies and melanoma]Émilie Routier, Caroline Robert, Christina Mateus
Hematology/Oncology Clinics of North America|July 24, 2024
Progress in Immune Checkpoint Inhibitor for Melanoma TherapyCeline Boutros, Hugo Herrscher, Caroline Robert
La Revue Du Praticien|October 15, 2020
[Immune checkpoint inhibitors for treatment of advanced stage melanoma]Jeremy Lupu, Hugo Herrscher, Caroline Robert
Melanoma Research|September 5, 2014
MAP-kinase pathway up or down? Just look at the skin of your patients!Caroline Robert, Marina Thomas, Christina Mateus
Progress in Tumor Research|September 19, 2015
Immune Checkpoint InhibitorsJohn B A G Haanen, Caroline Robert
Pageof 52